Intus Bio

Intus Bio is a biotechnology and health care startup based in the United States, founded in 2015. The company distinguishes itself with its slogan, "Revolutionary microbiome research, discovery, and testing." Intus Bio utilizes its proprietary high-resolution, high-throughput assay and analysis technology to present novel insights into the microbiome, offering unparalleled precision and scale. Its scope extends to groundbreaking research, discovery, and services within the global pharmaceutical, diagnostic, and testing industries, as well as in health, agricultural, and environmental fields. Moreover, the company remains committed to forging new and innovative partnerships, technologies, and applications in its pursuit of microbiome-related advancements. Most recently, Intus Bio secured $800.00K in Debt Financing investment on July 7, 2022. Although the specific investors were not disclosed, this investment attests to the perceived potential and promise of Intus Bio's endeavors within the microbiome research and testing space.